China, Nov. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy and Safety of Autologous Non-Cultured Epidermal Cell Transplantation with PrimCell Combined with CGF in the Treatment of Ischemic Refractory Wounds: A Multicenter, Randomized, Open-Label Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136597

Registration Time: 2026/11/12

Type: Interventional study

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335500

Published by HT Digital Content Services with permission from Health Daily Dige...